On central effects of serotonin re-uptake inhibitors: Quantitative EEG and psychometric studies with sertraline and zimelidine
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
In a double-blind placebo-controlled cross-over study the encephalotropic and psychotropic properties of sertraline--a new potent and highly selective inhibitor of synaptosomal serotonin uptake--were studied along with blood levels of the parent drug and main metabolite in ten normal healthy volunteers. They received randomized at weekly intervals oral single doses of placebo, 100, 200 and 400 mg setraline and 100 mg zimelidine as reference drug. Blood sampling, EEG recordings, psychometric tests and evaluation of pulse, blood pressure and side-effects were carried out at the hours 0, 2, 4, 6, and 8. Blood level investigations demonstrated that sertraline is slowly absorbed with dose-dependent blood concentrations peaking in the 4th to 6th hour and remaining high thereafter, while the main metabolite, CP-53261 exhibited an even slower rise in plasma concentration up to the 8th hour. Computer-assisted spectral analysis of the EEG demonstrated slight effects of 100 mg zimelidine and 100 mg sertraline on human brain function, but moderate to marked effects after 200 and 400 mg sertraline as compared with placebo. Changes after 100 mg sertraline and the reference compound resembled the pharmaco-EEG profiles of antidepressants of the desipramine type and were indicative of some vigilance-improving properties while higher doses of sertraline induced alterations reminiscent of those after antidepressants of the imipramine type, thereby reflecting vigilance changes of the dissociativ…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“single oral doses of 400 mg sertraline administered to healthy volunteers gave maximum plasma concentrations of 253.20 ± 112.29 ng/ml (~0.74μM) (Saletu et al., 1986)”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Saletu et al., 1986
Citations
Cites
Osgood, C. E., Suci, G. J., & Tannenbaum, P. H. (1957) · Cited by 9,433
5-HIAA in the Cerebrospinal Fluid: A Biochemical Suicide Predictor?
Åsberg, M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770100055005 · Cited by 1,445
Psychopharmacology: A Generation of Progress
Ananth, J. (1979) · Psychosomatics · doi:10.1016/s0033-3182(79)73729-7 · Cited by 844
5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides
Shaw, D. M., Camps, F. E., & Eccleston, E. G. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.505.1407 · Cited by 431
Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., Macdougall, E., Stanton, J. B., & Binns, J. K. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92028-9 · Cited by 373
BOURNE, H. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92459-8 · Cited by 304
Abnormalities of Indoleamines in Affective Disorders
Coppen, A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750230084016 · Cited by 304 · cited 1×
“, 1968) and from cerebral spinal fluid (CSF) data of patients with affective disorders (Ashcroft et al., 1966; Dencker et al., 1966; Shaw et al., 1969; Coppen et al., 1972).”
BackgroundOreland, L., Wiberg, Å., Åsberg, M., Träskman, L., Sjöstrand, L., Thorén, P., Bertilsson, L., & Tybring, G. (1981) · Psychiatry Research · doi:10.1016/0165-1781(81)90004-4 · Cited by 273 · cited 1×
“Oreland et al. (1981) described a bimodal distribution of CSF 5-HIAA in depressed patients, with the ones having lower values also showing greater suicidal behaviour.”
BackgroundKoe, B. K., Weissman, A., Welch, W. M., & Browne, R. G. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21773-6 · Cited by 257
ACID MONOAMINE METABOLITES OF CEREBROSPINAL FLUID IN MENTAL DEPRESSION AND MANIA
Dencker, S. J., Malm, U., Roos, B. ‐., & Werdinius, B. (1966) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1966.tb04320.x · Cited by 218 · cited 1×
“, 1968) and from cerebral spinal fluid (CSF) data of patients with affective disorders (Ashcroft et al., 1966; Dencker et al., 1966; Shaw et al., 1969; Coppen et al., 1972).”
BackgroundLloyd, K. G., Farley, I. J., Jh, D., & Hornykiewicz, O. (1974) · PubMed · Cited by 210
EEG and Human Psychopharmacology
Fink, M. (1969) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.09.040169.001325 · Cited by 172 · cited 1×
“Such alterations have been described by us and other investigators after antidepressants of the imipramine type (Fink, 1969; Itil, 1974; Saletu, 1976, 1982; Hermann, 1982) and are indicative of alterations in vigilance of the disassociative type, thereby reflect.”
BackgroundInteractions between putative neurotransmitters in the brain
Iversen, L. L. (1979) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(79)90163-1 · Cited by 165
Electroencephalography in Drug Research
Scott, D. (1983) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.11.1066-a · Cited by 144
Biochemical post-mortem findings in depressed patients
Birkmayer, W., & Riederer, P. F. (1975) · Journal of Neural Transmission · doi:10.1007/bf01663627 · Cited by 118
Zimelidine: A therapeutic and pharmacokinetic study in depression
Coppen, A. J., Rao, V. A. R., Swade, C., & Wood, K. (1979) · Psychopharmacology · doi:10.1007/bf00433549 · Cited by 115
l-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects
Murphy, D. L., Baker, M., Goodwin, F. K., Miller, H., Kotin, J., & Bunney, W. E. (1974) · Psychopharmacology · doi:10.1007/bf00421216 · Cited by 112 · cited 1×
“Indeed, some improvement in depression was seen with Ltryptophan as described by Dencker et al. (1966), Murphy et aL (1974) , Farkas et al. (1976), Coppen and Wood (1978) and Shaw (1977).”
Backgroundvon Zerssen, D., Koeller, D. M., & Rey, E. R. (1970) · PubMed · Cited by 101
Typical and Atypical Antidepressants—Clinical Practice
Gualtieri, C. T., & Golden, R. N. (1983) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198309000-00028 · Cited by 98
Quantitative Pharmaco-Electroencephalography
Itil, T. M. (2015) · Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry · doi:10.1159/000393857 · Cited by 85
Psychotropic drugs and the human EEG
Fink, M. (1975) · Comprehensive Psychiatry · doi:10.1016/0010-440x(75)90044-9 · Cited by 65
Saletu, B., & Grünberger, J. (1985) · PubMed · Cited by 64
Self-citationThe Practical Management of Affective Disorders
Shaw, D. M. (1977) · The British Journal of Psychiatry · doi:10.1192/bjp.130.5.432 · Cited by 52 · cited 2×
“Indeed, some improvement in depression was seen with Ltryptophan as described by Dencker et al. (1966), Murphy et aL (1974), Farkas et al. (1976), Coppen and Wood (1978) and Shaw (1977) .”
BackgroundMethodTryptophan and depressive illness
Coppen, A., & Wood, K. (1978) · Psychological Medicine · doi:10.1017/s0033291700006620 · Cited by 50 · cited 1×
“(1976), Coppen and Wood (1978) and Shaw (1977).”
Saletu, B., Schjerve, M., GR�NBERGER, J., Schanda, H., & Arnold, O. (1977) · Journal of Neural Transmission · doi:10.1007/bf01252962 · Cited by 48
Self-citationTOTAL AND NON-BOUND TRYPTOPHAN IN UNIPOLAR ILLNESS
Riley, G. J., & Shaw, D. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91180-6 · Cited by 41
Saletu, B., GR�NBERGER, J., Rajna, P., & Karobath, M. E. (1980) · Journal of Neural Transmission · doi:10.1007/bf01249190 · Cited by 40
Self-citationPharmaco-EEG profiles of typical and atypical antidepressants.
Saletu, B. (1982) · PubMed · Cited by 37
Self-citationFarkas, T., Dl, D., & Rr, F. (1976) · PubMed · Cited by 36
Behavior and anxiety: physiologic mechanisms.
Lehmann, H. E. (1983) · PubMed · Cited by 35
The new generation of antidepressants.
Feighner, J. P. (1983) · PubMed · Cited by 35
Claghorn, J. L., Gershon, S., Goldstein, B. J., Behrnetz, S., Bush, D. F., & Huitfeldt, B. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(83)90125-2 · Cited by 30
Long-Term Study of Fluvoxamine: a New Rapid-Acting Antidepressant
Feldmann, H. S., & Denber, H. C. B. (2017) · International Pharmacopsychiatry · doi:10.1159/000468564 · Cited by 27
Bánki, C. M., Molnar, G., & Fekete, I. (1981) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01833162 · Cited by 26
Lemberger, L., Terman, S., Rowe, H., & Billings, R. E. (1976) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1976.tb00595.x · Cited by 25
[Clinical psychodiagnosis using psychophysiologic procedures].
Grünberger, J., Linzmayer, L., & Saletu, B. (1984) · PubMed · Cited by 22
Self-citationFluvoxamine as an antidepressant drug
Doogan, D. P. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90207-5 · Cited by 19 · cited 1×
“Positive therapeutic results have bee reported, moreover, after administration of selective serotonin re-uptake inhibitors such as zimelidine (Coppen et aL, 1979; Montgomery et aL, 1982; Claghorn et aL, 1983), fluvoxamine (Saletu et aL, 1977; Feldmann and Denber, 1982; Doogan, 1980 ) and fluoxetine (Lemberger, 1976; F…”
BackgroundDetermination of pharmacodynamics of psychotropic drugs by psychometric analysis
Grünberger, J., & Saletu, B. (1980) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(80)90012-0 · Cited by 17 · cited 2×
“Again this is what we would expect from administration of higher doses of antidepressants in normals (Griinberger and Saletu, 1980; Spiegel and Aebi, 1981).”
BackgroundMethodSelf-citationSaletu, B., Grünberger, J., & Linzmayer, L. (1977) · PubMed · Cited by 15
Self-citationLevels of total and free tryptophan in the plasma of endogenous and neurotic depressives
Schmid‐Burgk, W., Kim, J. S., Lischewski, R., & Ra�mann, W. (1981) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00342828 · Cited by 9
The Use of the EEG for Assessment of Vigilance Changes Caused by Beta-Blockers
Matouŝek, M., Hjalmarson, Å. C., Koch, J. A., & Petersén, I. (2008) · Neuropsychobiology · doi:10.1159/000118110 · Cited by 7
Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
Sa, M., Db, M., McAuley, R., Sj, R., & Roy, D. (1982) · PubMed · Cited by 5
Research works printed but not linked: 8
- Grünberger J (1977) Psychodiagnostik des Alkoholkranken. Methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Maudrich, Wien
- Grünberger J, Linzmayer L, Saletu B (1984) Klinische Psychodiagnostik mit Hilfe psychophysiologischer Verfahren. Wien Med Wschr 134: 29?35
- Pfizer (1982) Central research: sertraline (CP-51, 974) ? investigators reference manual. Sandwich, England
- Saito M, Kita S, Kagono Y (1982) The orientation of psychotropic drug properties based on the induced changes in electroencephalogram. Studies on zimelidine and sulpiride. In: Herrmann WM (ed) EEG in drug research. G. Fischer, Stuttgart New York, pp 51?74
- Saletu B (1976) Psychopharmaka, Gehirntätigkeit und Schlaf. Karger, Basel
- Saletu B (1981) Application of quantitative EEG in measuring encephalotropic and pharmacodynamic properties of antihypoxidotic/nootropic drugs. In: Scientific International Research (ed) Drugs and methods in C.V.D. Pergamon Press, Oxford
- Spiegel R, Aebi H-J (1981) Psychopharmakologie. W Kohlhammer, Stuttgart Berlin Köln Mainz
- Zerssen VC, Koeller DM, Rey ER (1970) Die Befindlichkeitsskala (B-S) ? ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim-Forsch 20: 915?918
Cited by
Clinical Pharmacokinetics of Sertraline
DeVane, C. L., Liston, H. L., & Markowitz, J. S. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241150-00002 · Cited by 404
Serotonin and Blood Pressure Regulation
Watts, S. W., Morrison, S. F., Davis, R. P., & Barman, S. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004697 · Cited by 396
Wake and sleep EEG provide biomarkers in depression
Steiger, A., & Kimura, M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.08.013 · Cited by 302
Murdoch, D., & McTavish, D. (1992) · Drugs · doi:10.2165/00003495-199244040-00007 · Cited by 232
Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors
Healy, D. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068691 · Cited by 220
“Among the published studies with sertraline, 1 demonstrates a clear dose-dependent induction of agitation with sertraline [ 62 ].”
Background
Metadata
- Authors
- Saletu, B., Gr�nberger, J., & Linzmayer, L.
- Affiliations
- University of Vienna (AT)
- Venue
- Journal of Neural Transmission
- Published
- 1986-09
- Volume
- 67
- Issue
- 3-4
- Pages
- 241-266
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2035578288
- Cited by
- 78
- References
- 42
- Citations by year
- 2026: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- sertraline, zimelidine, selective serotonin reuptake inhibitors, pharmaco-EEG, plasma drug concentration, dose-dependent effects, sustained attention, psychometric performance, psychophysiological effects, pupil dilation, antidepressants, pharmacodynamics, adverse effects, blood pressure, pulse rate
- MeSH terms
- Adult, Brain, Double-Blind Method, Electroencephalography, Female, Humans, Male, Mental Processes, Naphthalenes, Psychological Tests, Psychotropic Drugs, Zimeldine, 1-Naphthylamine, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.